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Regulatory T Cells Resist Virus Infection-Induced Apoptosis
Jenny W. Che,* Anke R. M. Kraft,* Liisa K. Selin, Raymond M. Welsh
Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
ABSTRACT
Regulatory T (Treg) cells are important in the maintenance of self-tolerance, and the depletion of Treg cells correlates with auto-
immune development. It has been shown that type I interferon (IFN) responses induced early in the infection of mice can drive
memory (CD44hi) CD8 and CD4 T cells into apoptosis, and we questioned here whether the apoptosis of CD44-expressing Treg
cells might be involved in the infection-associated autoimmune development. Instead, we found that Treg cells were muchmore
resistant to apoptosis than CD44hi CD8 and CD4 T cells at days 2 to 3 after lymphocytic choriomeningitis virus infection, when
type I IFN levels are high. The infection caused a downregulation of the interleukin-7 (IL-7) receptor, needed for survival of con-
ventional T cells, while increasing on Treg cells the expression of the high-affinity IL-2 receptor, needed for STAT5-dependent
survival of Treg cells. The stably maintained Treg cells early during infectionmay explain the relatively low incidence of autoim-
munemanifestations among infected patients.
IMPORTANCE
Autoimmune diseases are controlled in part by regulatory T cells (Treg) and are thought to sometimes be initiated by viral infec-
tions. We tested the hypothesis that Treg may die off at early stages of infection, when virus-induced factors kill other lympho-
cyte types. Instead, we found that Treg resisted this cell death, perhaps reducing the tendency of viral infections to cause immune
dysfunction and induce autoimmunity.
Regulatory T (Treg) cells play an important role in maintainingself-tolerance and limiting an overactive immune response.
Immunosuppressive “natural” Treg cells develop in the thymus
and are marked by the expression of CD4 and a Forkhead/winged-
helix family member, forkhead box P3 (Foxp3; Scurfin), which is
an activator and a repressor of transcriptional control (1). Scurfy
mice, which have a 2-bp insertion in their exon 8 of the X-linked
Foxp3 gene (2), develop a lymphoproliferative disorder and
perivascular infiltration of hematopoietic cells in multiple periph-
eral organs (3). Depletion of the Foxp3-expressing population in
mice can lead to autoimmune disorders (4–6). Under the tran-
scriptional control of Foxp3, Treg cells express a high level of
interleukin-2 (IL-2) receptor  (CD25) and a low level of IL-7
receptor  (CD127) on the cell surface (7). Treg cells do not pro-
duce IL-2 or tumor necrosis factor (TNF) but instead depend on
common  chain cytokines from other cells for survival (7, 8).
CD8 and CD4 T cells, particularly those of the memory phe-
notype, undergo apoptosis and decline in number early (days 2 to
4) during viral (9–11) and some bacterial (12) infections. This
attrition is mediated in part by type I interferon (IFN) and occurs
after infection with type I IFN-inducing pathogens or after treat-
ment of mice with the type I IFN-inducer poly(I·C). This attrition
and apoptosis can be blocked by antibody to type I IFN (13) and is
dramatically reduced in type I IFN receptor (IFNAR) knockout
(KO) mice (9, 14). Memory CD8 and CD4 T cells express high
levels of CD44, and these CD44hi cells show the highest levels of
apoptotic loss at the early stage of infection, perhaps making room
for a new immune response to rapidly develop (14).
Infection has been implicated as a potential trigger in autoim-
mune diseases (15–18), but underlying mechanisms have yet to be
clarified. One of the theories is that infection may disrupt the
balance of immune regulation, perhaps through Treg cells, in the
susceptible organs (18, 19). Foxp3 CD4 Treg cells exhibit a
partial memory phenotype with an intermediate to high expres-
sion of the activation and memory marker CD44 (20). Therefore,
we questioned whether Treg cells may behave like the CD44hi
CD4 and CD44hi CD8 T cells and get driven into apoptosis and
decline in number during early stages of infection. If so, their
demise might contribute to the phenomenon of virus-induced
autoimmunity.
MATERIALS AND METHODS
Mice and virus stocks. Foxp3-GFP knock-in mice, a kind gift from Vijay
K. Kuchroo (21), were bred and maintained in a specific-pathogen-free
facility at the University of Massachusetts Medical School (UMMS)
(Worcester, MA). C57BL/6 mice between 4 to 6 weeks of age were pur-
chased from the Jackson Laboratory. Experiments were done when mice
reached at least 6 to 7 weeks of age.
Lymphocytic choriomeningitis virus (LCMV) strain Armstrong was
propagated in baby hamster kidney BHK21 cells (22, 23). Mice were in-
oculated intraperitoneally (i.p.) with 5 104 PFU of LCMV stock. Injec-
tion with supernatant from uninfected BHK21 cell cultures (BHK) was
used as a sham control in some experiments. Experiments were done in
compliance with the Animal Welfare Act and the National Institutes of
Health guidelines for the ethical care and use of animals in biomedical
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research, according to protocols approved by the Institutional Animal
Care and Use Committee of UMMS.
Surface staining. Splenocytes in suspension were washed in staining
buffer (1% fetal calf serum [FCS] in phosphate-buffered saline [PBS]),
blocked with anti-CD16/32 monoclonal antibody (MAb; clone 2.4G2; Fc
block), stained with anti-CD4 (clone RM4-5), anti-CD8 (clone 53-6.7),
anti-CD8 (clone YTS156.7.7), anti-CD44 (clone IM7), anti-CD25
(clone PC61.5), anti-CD127 (clone A7R34), anti-CD122 (clone TM-1),
anti-CD132 (clone TUGm2), and anti-Thy1.2 (clone 30-H12) antibodies,
and Live/Dead Fixable Aqua (Invitrogen) for 20 min at 4°C, and fixed with
CytoFix (BD Biosciences) for 5 min at 4°C. Samples were resuspended in
staining buffer until reading by an LSRII flow cytometer (BD Biosciences).
Collected data were analyzed by FlowJo software (Tree Star).
TUNEL assay. To evaluate DNA fragmentation, cells were rested in
medium (10% FCS in RPMI 1640 with 2 mM penicillin-streptomycin and
2 mM L-glutamine; Gibco) supplemented with 10 mM HEPES in a 48-well
plate for 5 h at 37°C and 5% CO2, Fc blocked, surface stained, and sub-
jected to CytoFix for 15 min at 4°C. After permeabilization with 70%
(vol/vol) ethanol for 3.5 days at20°C, terminal deoxynucleotidyl trans-
ferase dUTP-biotin nick end labeling (TUNEL) was performed using the
Apo-BrdU-Red In Situ DNA Fragmentation Assay kit (BioVision) ac-
cording to the manufacturer’s instructions. Samples were analyzed within
3 h by LSRII.
Annexin V staining. Annexin V staining was done directly ex vivo.
After the Fc block, surface staining, and one wash with annexin V binding
buffer (eBioscience), cells were stained with annexin V (eBioscience) at
room temperature for 15 min. Samples were analyzed immediately by
LSRII.
PhosFlow staining. Splenocytes in suspension were stimulated with
IL-2 (5 ng/ml; BD Biosciences) for 15 min at 37°C, 5% CO2. After a quick
wash in staining buffer, cells were immediately fixed with CytoFix for 15
min at 4°C, Fc blocked, and surface stained as described above. Cells were
then permeabilized with PhosFlow Perm buffer III (BD Biosciences) for
30 min on ice and stained with anti-STAT5 (clone 3H7) or anti-pSTAT5
(clone pY694) for 60 min at room temperature in the dark. Samples were
resuspended in staining buffer until analysis by LSRII.
Statistical analysis. Student’s t test was calculated using Excel or
Prism software. Data are presented as means and standard errors of the
means (SEM).
RESULTS
Insignificant reduction of Foxp3CD4 Treg cells after LCMV
infection. As an initial screen to determine if there was a loss in
Treg cells during viral infection, C57BL/6 mice were infected in-
traperitoneally with strain Armstrong of LCMV and examined for
CD8, CD4, and Treg cell phenotype and number. In a time course
study, mice were examined every 4 days for 2 weeks and then every
7 days for 2 more weeks to determine the stability of the Treg cell
population. Figure 1 depicts the frequency (Fig. 1a) and total
number (Fig. 1b) of Foxp3 CD4 Treg cells as well as CD8 and
non-Treg CD4 T cells in the spleen at these different time points.
It shows the well-established dramatic rise of the CD8 T cells ver-
sus the more stable CD4 T cell number, reflecting the reversal of
the CD4 to CD8 T cell ratio during an acute viral infection. The
Treg population, however, remained relatively stable during this
4-week time period. This stability of the Treg population was also
seen when Treg numbers were separately examined at 0, 2, and 3
days postinfection in many additional experiments as described
below.
Normally, at early stages (days 2 to 3) of viral infection, there is
a substantial type 1 IFN-induced apoptosis-driven loss in CD8
and CD4 T cells expressing the CD44hi memory phenotype. To
examine whether Treg cells, which express intermediate to high
levels of CD44, are resistant to apoptosis at these very early time
points, we examined their apoptosis and attrition in more detail.
LCMV induces type I IFN, which peaks at day 2 postinfection (24).
Splenocytes from infected Foxp3-GFP knock-in mice and age-
matched naive controls were harvested at this type I IFN peak 2
days postinfection and analyzed by flow cytometry (Fig. 2). While
the frequency of Foxp3-negative CD44hi CD4 and CD44hi CD8 T
cells among lymphocytes decreased considerably after LCMV in-
fection, the frequency of Foxp3 CD4 T cells was only slightly
reduced (Fig. 2b), and the frequency of Foxp3 CD4 T cells
among CD4 T cells before and after LCMV infection was not
significantly different (11.6% 0.75% versus 10.7% 2.1%, P	
0.24). The actual number of T cells in the spleen was then calcu-
lated for each individual mouse using their total splenocyte counts
separately. As expected, CD44hi CD4 and CD44hi CD8 T cells
declined significantly in number (Fig. 2c). However, the total
number of Foxp3 CD4 T cells did not significantly change after
infection (Fig. 2c). At day 3 following LCMV infection, a small but
consistent decline in the frequency of Foxp3 CD4 T cells was
observed in the spleen (Fig. 2d), but the total number of Foxp3
CD4 T cells in the spleen of infected animals was not significantly
different from that of naive animals (Fig. 2e). Therefore, the pres-
ence of Foxp3 CD4 T cells in the spleen is relatively stable early
during LCMV infection.
Infection can cause Foxp3 CD4 T cells to traffic between the
FIG 1 Relatively stable Foxp3 CD4 Treg cell numbers during LCMV in-
fection. C57BL/6 mice were infected i.p. with 5  104 PFU of LCMV strain
Armstrong, and the spleen was examined every 4 days over 4 weeks for the
frequency (a) and total number (b) of CD8 T, Foxp3CD4Treg, and Foxp3-
negative CD4 T cells. Each time point represents 3 to 14 mice.
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secondary lymphoid organs. Therefore, the Treg cells from ingui-
nal, axillary/brachial, and mesenteric lymph nodes were examined
after LCMV infection, and we found no significant changes in the
number and frequency of Treg cells at days 2 and 3 postinfection
(data not shown).
Foxp3 CD4 T cells are resistant to apoptosis during LCMV
infection. Cell death by apoptosis is a coordinated process that
ultimately leads to DNA fragmentation. The 3=-OH end of the
fragmented or nicked DNA can be visualized by TUNEL assay,
which covalently attaches a dUTP to the 3=-OH end. Subsequent
labeling with a fluorescence-conjugated anti-dUTP antibody al-
lows quantitative assessment of DNA fragmentation by flow cy-
tometry. A previous study showed that both CD44hi CD8 and
CD44hi CD4 T cells in the spleen were more TUNEL positive after
poly(I·C) treatment (11). Infection with LCMV also increases the
frequency of TUNEL-positive CD44hi CD8 T cells in the spleen
early after infection (11), and tissue sections have shown two
peaks of TUNEL-positive splenocytes after LCMV infection: one
at day 3, closely following the peak of the type I IFN response,
which we examined here, and the other at day 11, as the response
enters the contraction phase (25).
To test if Treg cells were sensitive to virus infection-induced
apoptosis, splenocytes were harvested from Foxp3-GFP mice at
day 2 after LCMV infection, rested in medium at 37°C for 5 h, and
stained with the TUNEL assay (Fig. 3). Without infection, CD44hi
Foxp3-negative CD4 T cells and Foxp3 CD4 Treg cells ap-
peared to be more TUNEL positive than CD8 T cells (Fig. 3a).
Infection with LCMV increased the percentage of TUNEL-posi-
tive CD4 and CD8 T cells but had no effect on Foxp3CD4 T cells.
As expected, the increase in apoptotic events among CD44hi T
cells was more dramatic than that among CD44lo T cells after
LCMV infection (Fig. 3b). Although Foxp3 CD4 Treg cells
from naive mice had a measurable TUNEL background, their lev-
els of apoptosis were similar to those of the relatively resistant
CD44lo CD4 and CD44lo CD8 T cells at day 2 after LCMV infec-
tion, and they were much less apoptotic than CD44hi CD4 and
CD44hi CD8 T cells.
Activated caspase disturbs the asymmetry of the plasma mem-
brane, causing exposure of phosphatidylserine on the cell surface
(26). Therefore, apoptosis of splenocytes from LCMV-infected
Foxp3-GFP mice was also examined ex vivo with amine-reactive
live/dead stain and annexin V, which binds to exposed phospha-
tidylserine. Similar to the data from the TUNEL assay, Foxp3-
negative CD44hi CD4 T cells were highly annexin V positive, even
among cells from naive spleens (Fig. 4). Annexin V reactivity
among CD4 and CD8 T cells increased after LCMV infection but
remained low among Foxp3 CD4 Treg cells.
Similar results were observed at day 3 after LCMV infection.
Foxp3 CD4 T cells from naive animals displayed some TUNEL
and annexin V background reactivities, but their staining intensity
was not increased by LCMV infection, while CD8- and Foxp3-
negative CD4 T cells, especially their CD44hi subsets, became
much more TUNEL and annexin V positive after infection (Fig.
5). Both the TUNEL and annexin V data therefore indicate that
Foxp3 CD4 Treg cells are much more resistant to virus infec-
tion-induced apoptosis than CD44hi CD4 and CD44hi CD8 T
cells in the spleen.
Survival factors regulating T cell apoptosis. Cellular apopto-
sis is generally regulated by a balance between intracellular pro-
and antiapoptotic proteins and the availability of survival cyto-
FIG 2 Foxp3CD4 Treg cells resist loss after LCMV infection in comparison to CD44hi CD8 and CD44hi Foxp3-negative CD4 T cells. Foxp3-GFP mice were
infected i.p. with 5  104 PFU LCMV. Two (b and c) or 3 (d and e) days later, surface-stained splenocytes from infected and uninfected (naive) mice were
analyzed by flow cytometry, with gating as shown in panel a. (b and d) The frequencies of CD8 T cells and Foxp3CD4Treg cells were obtained by direct gating,
while the frequency of Foxp3-negative CD4 T cells was calculated by Boolean gating in FlowJo. (c and e) The absolute numbers of the different populations were
then calculated from the total live splenocyte counts. (b and c) Combined data from 3 separate experiments (n	 9). (d and e) Representative data from seven
separate experiments (n	 3). *, statistical significance (P
 0.05) between naive and LCMV-infected groups.
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kines and their receptors. The complete mechanism behind the
type I IFN-induced apoptosis of memory T cells during viral in-
fection remains unclear, and it is also not certain if the mechanism
of apoptosis for the CD44hi CD8 T cells is the same as that for the
CD44hi CD4 T cells. However, it has been shown that the apo-
ptosis of these T cells requires the proapoptotic molecule Bim and
that it occurs in T cells lacking CD127, the receptor for the T cell
survival factor IL-7 (11, 27). Treg cells are reported to express very
high levels of CD25 (7), and their survival is correlated with IL-2-
mediated signaling of STAT5 (28, 29). We therefore examined
each of these factors in uninfected and day 2 LCMV-activated T
cell populations and determined how they correlated with apo-
ptosis.
Although our previous study had shown that the proapoptotic
Bim molecule was required for apoptosis of memory T cell popu-
lations (11), examination by flow cytometry found no correlation
between proapoptotic Bim or BAK expression and the apoptotic
cell populations within the uninfected and LCMV-inoculated na-
ive (CD44lo) and memory (CD44hi) CD4 and CD8 T cell popu-
lations and Treg populations. There also was no correlation be-
tween expression of the antiapoptotic proteins Bcl-2, Bcl-xL, or
Mcl-1 or of the ratio between the pro- and antiapoptotic proteins
throughout these five gated cell populations (data not shown).
Failing to find illuminating results by examining pro- and anti-
apoptotic molecule expression, we focused on the expression of
cytokine receptors. It has been shown that IL-7 signaling is critical
for the survival of naive (30, 31) and memory (32, 33) T cells in the
periphery, whereas IL-2 is important for Treg cell maintenance
(34). Therefore, we examined the surface expression of CD127,
FIG 3 Foxp3 CD4 Treg cells are less TUNEL positive than CD44hi Foxp3-
negative CD4 and CD44hi CD8 T cells in the spleen at day 2 following LCMV
infection. Foxp3-GFP mice were infected i.p. with 5  104 PFU LCMV.
Splenocytes harvested at 2 days postinfection were stained with TUNEL after
incubating in medium at 37°C for 5 h. (a) Histograms of TUNEL staining
intensity of CD4, CD8, and Treg cells from a naive animal and a day 2 LCMV-
infected animal in a representative experiment. (b) Combined data from 3
separate experiments (total n 	 9). *, statistical significance (P 
 0.05) be-
tween naïve mice and mice at day 2 following LCMV infection. (c) A repre-
sentative panel of dot plots showing TUNEL reactivity versus CD44 staining
among CD4 T cells, CD8 T cells, and Treg cells.
FIG 4 Foxp3 CD4 Treg cells are less annexin V positive than CD8 and
Foxp3-negative CD4 T cells in the spleen at day 2 following LCMV infection.
Foxp3-GFP mice were infected i.p. with 5  104 PFU LCMV. Splenocytes
harvested at 2 days postinfection were stained ex vivo with Live/Dead Fixable
stain and annexin V. (a) Histograms of annexin V staining intensity of live
CD4, CD8, and Treg cells from a naive animal and a day 2 LCMV-infected
animal in a representative experiment. (b) Data are from a representative of
three separate experiments (n 	 3). *, statistical significance (P 
 0.05) be-
tween naive cells and cells at day 2 following LCMV infection. (c) Representa-
tive panel of dot plots showing annexin V reactivity versus CD44 staining
among CD4 and CD8 T cells and Treg cells.
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CD25, IL-2 receptor (CD122), and the common cytokine recep-
tor  chain (CD132) on T cells in naive and LCMV-infected
Foxp3-GFP mice (where GFP is green fluorescent protein) at day
2 postinfection (Fig. 6). As published previously (35), surface ex-
pression of CD127 on Foxp3 CD4 T cells was much lower than
that on Foxp3-negative CD4 T cells in the spleen. CD127 expres-
sion on CD44hi Foxp3-negative CD4 T cells was lower than that
on CD44hi CD8 T cells (Fig. 6b). After LCMV infection, CD127
was downregulated in all CD8 and CD4 T cells regardless of Foxp3
or CD44 expression status. This downregulation of receptors for
this T cell survival cytokine after viral infection may therefore have
made conventional CD4 and CD8 T cells more susceptible to
apoptosis. Expression of CD25 was high on Foxp3 CD4 Treg
cells but was negligible on all other CD4 and CD8 T cells (Fig. 6c).
LCMV infection, in contrast to its lowering of expression of
CD127, upregulated CD25 expression on Treg cells substantially
but did not affect the low levels of expression of CD25 on other
CD4 or CD8 T cells at day 2 postinfection. As published previously
(36), expression of CD122 was the highest on CD44hi CD8 T cells
but very low on CD44lo CD4 T cells. We found that Foxp3CD4
Treg cells expressed higher levels of CD122 than Foxp3-negative
CD4 T cells and CD44lo CD8 T cells (P 
 0.02), and CD122
expression was not changed much by LCMV infection (Fig. 6d).
All CD4 and CD8 T cells and Treg cells expressed CD132 (Fig. 6e).
Although the expression of CD132 was elevated on Foxp3-nega-
tive CD4 and CD8 T cells after LCMV infection, it was unchanged
on Treg cells. The pattern of receptor expression indicates that
although LCMV infection downregulates the IL-7 receptor on all
T cells, the high-affinity IL-2 receptor remains intact or is more
highly expressed on Treg cells. This may provide a survival advan-
tage to the Treg cells.
STAT5A and STAT5B mediate IL-2 and IL-7 signaling (28, 37,
38). Phosphorylated STAT5 is involved not only in sustaining
Foxp3 expression (39) but also in regulating CD8 T cell homeo-
stasis (40, 41). PhosFlow staining was used to examine the intra-
cellular STAT5 and its phosphorylated form. The percentages of
CD4 and CD8 T cells were similar to those obtained by surface
staining alone. When the expression levels of STAT5 before and
after LCMV infection were compared, we found that the total
expression of STAT5 was the highest among Foxp3 CD4 T cells
in naive animals and was marginally increased after LCMV infec-
tion (Fig. 7a). In contrast, the total STAT5 expression was slightly
reduced among CD8 T cells (both CD44hi and CD44lo) and
CD44lo Foxp3-negative CD4 T cells after infection. Consistent
with the expression pattern of CD25 (Fig. 6b), only Treg cells were
able to respond to IL-2 stimulation in vitro and phosphorylate
STAT5 (Fig. 7b). A time course experiment also revealed that
STAT5 in Foxp3 CD4 T cells could be phosphorylated in re-
sponse to IL-2 within seconds of encounter (data not shown).
Therefore, the ability of Foxp3 CD4 Treg cells to receive sur-
vival signals through IL-2 receptor and STAT5 was not dimin-
ished early during LCMV infection.
DISCUSSION
Previous work had established that CD44hi CD8 and CD44hi
CD4 T cells are driven to apoptosis by virus infection- and
poly(I·C)-induced type I IFN (9, 11, 13, 14). The current study
extends our knowledge to the Foxp3 CD4 natural Treg cells.
Treg cells are major regulators of self-reactive T cells and are
strong suppressors of autoimmunity. There are several experi-
mental models of virus-induced autoimmunity in animals, and
there are epidemiological correlates linking viral infections to the
induction or exacerbations of a variety of autoimmune diseases,
including diabetes, multiple sclerosis, rheumatoid arthritis, myo-
carditis, etc. (15, 42). A possible mechanism for virus-induced
autoimmunity could be a consequence of the infection-induced
apoptosis of Treg cells, because a transient loss of Treg cells is
sufficient to initiate an autoimmune disorder (34). However,
most of the time viruses do not induce autoimmunity. It is not
uncommon to see some self-reactive antibodies generated during
infection (43–45), but most of the time the host survives a viral
infection without serious autoimmune manifestations. It was,
therefore, of interest to determine whether Foxp3CD4 natural
Treg cells, present at the beginning of viral infections, were resis-
tant or sensitive to the T cell apoptosis that occurs early during
infection. Human Treg cells are more resistant to apoptosis in-
duced by irradiation or a topoisomerase inhibitor than non-Treg
CD4 T cells (46), and both murine and human Treg cells are
resistant to activation-induced cell death (47, 48). Here we show
that Treg cells were substantially more resistant to viral infection-
induced apoptosis than were the CD44hi CD4 and CD8 memory
T cells with which they coexist. This resistance of Treg cells to
apoptosis could be part of the explanation why autoimmunity,
which can occur after a virus infection, is relatively rare.
Treg cells might be more resistant to virus infection-induced
apoptosis because of their ability to receive signals from IL-2. Both
IL-7 and IL-2 have been shown to affect Treg population size in
FIG 5 Foxp3 CD4 Treg cells are less apoptotic than CD44hi Foxp3-nega-
tive CD4 and CD8 T cells in spleen at day 3 following LCMV infection. Foxp3-
GFP mice were infected i.p. with 5 104 PFU LCMV. Splenocytes harvested at
3 days postinfection were stained with TUNEL after incubating in medium at
37°C for 5 h (a) or ex vivo with Live/Dead Fixable stain and annexin V (b). Data
are representative of at least three separate experiments (n 	 3). *, statistical
significance (P
 0.05) between naive cells and cells at day 3 following LCMV
infection.
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the periphery through regulating Foxp3 expression (49, 50).
Foxp3 as a transcription factor can downregulate the expression of
CD127 but upregulate CD25 expression (7), resulting in mature
Treg cells being CD127lo and CD25hi. Recent work has also iden-
tified a CD127hi Foxp3 population in bone marrow and in skin
(35), but these were not examined in this study. Upon LCMV
infection, CD127 expression was further reduced on Foxp3
CD4 Treg cells, but the expression of CD25, CD122, and CD132
FIG 6 The IL-7 receptor is downregulated on T cells, while the high-affinity IL-2 receptor remains on Foxp3CD4Treg cells after LCMV infection. Foxp3-GFP
mice were infected i.p. with 5 104 PFU LCMV. Splenocytes harvested at 2 days postinfection were stained ex vivo for CD127 (b), CD25 (c), CD122 (d), and
CD132 (e), and the T cell populations were analyzed by flow cytometry (a). Data are representative of at least three separate experiments showing geometric mean
fluorescence intensity between naive mice and mice at day 2 following LCMV infection (n	 3). *, statistical significance (P
 0.05) between naive mice and mice
at day 2 following LCMV infection (n	 3). Histograms of a representative animal from each group were overlaid for visual comparison.
Regulatory T Cells Resist Apoptosis
February 2015 Volume 89 Number 4 jvi.asm.org 2117Journal of Virology
 o
n
 Septem
ber 24, 2015 by UNIV O
F M
ASS M
ED SCH
http://jvi.asm.org/
D
ow
nloaded from
 
was either increased or unchanged. The ability to continue to re-
ceive survival signals through the IL-2/STAT5 pathway may allow
Treg cells to survive and maintain functionality during infection.
A high dose (1 mg/mouse) of IL-2-neutralizing antibody has been
shown to deplete Foxp3 CD25 CD4 Treg cells over 3 days in
vivo (34), and the presence of IL-2 (0.1 to 10 ng/ml) has been
shown to protect CD25CD4Treg cells but not CD25 conven-
tional CD4 T cells from spontaneous and dexamethasone-in-
duced cell death in a 12-h in vitro assay (51). Our preliminary
attempt to induce Treg cell death by adding a depleting anti-IL-2
antibody similarly supported the role of IL-2 in Treg cell survival,
though more tests are needed to confirm the observation.
The downregulation of CD127 might have made T cells more
sensitive to apoptosis. CD127 is thought to be downregulated in
response to T cell activation, but CD127 expression on wild-type
(WT) donor CD8 T cells is much higher in IFNAR KO hosts than
in WT hosts after acute LCMV infection (52). It is noteworthy that
the early apoptosis of memory T cells does not occur in LCMV-
infected IFNAR KO mice. Thus, type I IFN probably indirectly
downregulates CD127 on T cells as it induces their apoptosis.
While the expression of CD127 is important for naive and mem-
ory CD8 T cell survival, signaling through the IL-7 receptor is not
required during the initial proliferative response to an infection or
immunization (32). Decreasing the sensitivity of T cells to IL-7
through downregulation of CD127 may be a way to allow the
selection and programming of responding T cells by other cyto-
kines to generate specific responses to newly encountered antigens
while simultaneously eliminating some preexisting memory T
cells.
Two recent reports have examined the effects of type I IFN on
Treg cells under inflammatory conditions. One concludes that
type I IFN may actually act to maintain Foxp3 expression and Treg
activity, a result wholly consistent with our observations of Treg
cell resistance to IFN-induced apoptosis (53). A second paper us-
ing the LCMV system notes that type I IFN serves to inhibit the
proliferation of Treg cells at later stages of infection (54). Clearly,
IFN can have many effects on Treg and other types of immune
cells, but the early apoptosis of Treg cells does not seem to be one
of them.
Previous attempts to decipher the mechanism of memory
CD44hi CD8 T cell apoptosis and early attrition induced by type I
IFN had not established any connection to NK cells, gamma in-
terferon receptor (IFN-R), perforin, FasL, granzyme B, TNF-
related apoptosis-inducing ligand (TRAIL), TNF receptor 1
(TNFR1), or TNFR2 (9) (K. Bahl and R. M. Welsh, unpublished
data). However, Bim is instrumental to the process. In Bim KO
mice, the frequency of CD44hi CD8 T cells is relatively stable after
LCMV infection, and the CD44hi CD8 T cells are substantially less
TUNEL positive at day 3 postinfection with LCMV (11). Bim can
physically interact with Bcl-2, Bcl-xL, and Mcl-1 to initiate apop-
tosis (55, 56). Since Treg cells are more resistant to virus infection-
induced early apoptosis, it was expected that the relative abun-
dance of antiapoptotic and proapoptotic molecules might be
different between Treg cells and the CD44hi CD8 and CD4 T cells.
However, the mean fluorescence intensity (MFI) ratios of Bim to
antiapoptotic molecule did not increase with the increased occur-
rences of apoptosis observed in the CD44hi CD8 and CD4 T cells
after LCMV infection (data not shown).
The functions of Treg cells may make them useful to be pre-
served during infections and yet inevitably problematic in some
circumstances. Treg cells play a critical role of regulating effector T
cells, NK cells, neutrophils, monocytes, and macrophages early
during viral infections, mitigating the pathology incurred by the
immune response and prolonging survival of the infected mice
(57–60). The presence of virus-specific memory Treg cells can
preserve lung function by limiting CD8 T cell response and reduc-
FIG 7 Foxp3 CD4 Treg cells display the highest level of STAT5 expression
and respond well to IL-2 stimulation in vitro even after LCMV infection.
Foxp3-GFP mice were infected i.p. with 5 104 PFU LCMV. (a) Splenocytes
harvested at 2 days postinfection were stained ex vivo for STAT5. (b) Phos-
phorylation of STAT5 (pSTAT5) was assessed among CD44hi CD8 (solid red),
CD44lo CD8 (solid blue), CD44hi Foxp3-negative CD4 (solid green), CD44lo
Foxp3-negative CD4 (solid orange), and Foxp3CD4 (solid gray) T cells from
a representative naive animal and Foxp3 CD4 T cells (black line) from a day
2 LCMV-infected animal after stimulating splenocytes with 5 ng/ml IL-2 for 15
min at 37°C. Data are representative of two separate experiments showing
geometric mean fluorescence intensity between BHK sham control or naive
versus day 2 LCMV-infected groups of 2 or 3 mice.
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ing pathology during homologous influenza rechallenge (61).
However, during heterologous infections, the nature of their per-
sistence may also pose a problem, as demonstrated in the influ-
enza A virus-immune mice during intranasal LCMV challenge, in
which the higher number of Treg cells contribute to more-severe
immunopathology in the immune mice by preventing exhaustion
of responding CD8 T cells and supporting migration of CD8 T
cells into the lungs (62).
The association between infection, IFN therapy, and autoim-
munity (63–65) had us questioning whether virus-induced type I
IFN might drive Treg cells into apoptosis and reduction in num-
ber, thereby allowing activation of autoreactive cells. Our study,
however, indicates that the Foxp3 CD4 natural Treg popula-
tion is relatively stable early during LCMV infection. Similarly,
our preliminary studies with mice treated with type I IFN inducer
poly(I·C) for 1 day also showed more stable Foxp3 Treg cells by
TUNEL assay (data not shown), suggesting that type I IFN may
not compromise the survival of natural Treg cells. This may ex-
plain why the autoimmunity that develops in IFN-treated or in-
fected patients is at a relatively low frequency. Many other factors
are involved in the development of autoimmunity, and further
investigation will be needed to dissect the specific process for each
autoimmune disease.
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